Literature DB >> 21116048

Clinical research participation among aging adults enrolled in an Alzheimer's Disease Center research registry.

Angela L Jefferson1, Susan Lambe, Christine Chaisson, Joseph Palmisano, Kathy J Horvath, Jason Karlawish.   

Abstract

In light of our limited understanding of what motivates older adults to participate in clinical studies of Alzheimer's disease (AD), the current study examines incentives and barriers to participating in AD clinical research among older adults. 235 participants enrolled in the Boston University Alzheimer's Disease Center research registry (75 ± 8 years, range 58-99 years, 60% female), a longitudinal registry from which individuals are recruited into other clinical studies, completed a survey assessing registry participation satisfaction, religiousness, trust in healthcare institutions, and medical research attitudes. Most participants reported initially enrolling in the registry for societal benefit. Insufficient time was a commonly endorsed barrier to enrolling in other Center-approved studies, particularly among younger participants. Driving and a lack of transportation to the medical facility were also barriers, particularly for older participants. Transportation was the most popular incentive, followed by home-based visits (particularly for older participants and participants with less formal education) and compensation (particularly among respondents from racial/ethnic minority groups). Participation interest in other studies was associated with favorable medical research attitudes (r = 0.34, p = 0.00003) but not religiousness (r = -0.09, p = 0.21), or trust in healthcare institutions (r = 0.09, p = 0.17). Among older adults, societal benefit is a motivating factor for registry enrollment; however, participation in additional studies is hindered by insufficient time among younger participants and transportation barriers among older participants. Providing transportation, home-based visits, and modest compensation may improve participation rates. Furthermore, favorable attitudes toward medical research are strongly associated with interest in enrolling in additional studies and may serve as a beneficial outreach triage technique.

Entities:  

Mesh:

Year:  2011        PMID: 21116048      PMCID: PMC3178330          DOI: 10.3233/JAD-2010-101536

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  30 in total

1.  Primary prevention studies and the healthy elderly: evaluating barriers to recruitment.

Authors:  M Boles; W S Getchell; G Feldman; R McBride; R G Hart
Journal:  J Community Health       Date:  2000-08

Review 2.  The recruitment of normal healthy volunteers: a review of the literature on the use of financial incentives.

Authors:  Carl L Tishler; Suzanne Bartholomae
Journal:  J Clin Pharmacol       Date:  2002-04       Impact factor: 3.126

3.  Development and testing of the health care system distrust scale.

Authors:  Abigail Rose; Nikki Peters; Judy A Shea; Katrina Armstrong
Journal:  J Gen Intern Med       Date:  2004-01       Impact factor: 5.128

4.  Recruitment and retention of ethnic minority elders into clinical research.

Authors:  Yaron G Rabinowitz; Dolores Gallagher-Thompson
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jul-Sep       Impact factor: 2.703

5.  Attitudes towards clinical research amongst participants and nonparticipants.

Authors:  S M Madsen; M R Mirza; S Holm; K L Hilsted; K Kampmann; P Riis
Journal:  J Intern Med       Date:  2002-02       Impact factor: 8.989

6.  Caregivers' attitudes toward their family members' participation in Alzheimer disease research: implications for recruitment and retention.

Authors:  C M Connell; B A Shaw; S B Holmes; N L Foster
Journal:  Alzheimer Dis Assoc Disord       Date:  2001 Jul-Sep       Impact factor: 2.703

7.  Reasons for entry into and understanding of HIV/AIDS clinical trials: a preliminary study.

Authors:  M W Ross; K Jeffords; J Gold
Journal:  AIDS Care       Date:  1994

Review 8.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

9.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

10.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08
View more
  23 in total

1.  Alzheimer Disease Clinical Trial Recruitment: Does Participation in a Brief Cognitive Screen at a Community Health Fair Promote Research Engagement?

Authors:  Justin M Barber; Shoshana H Bardach; Gregory A Jicha
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

2.  Obstacles and opportunities in Alzheimer's clinical trial recruitment.

Authors:  Jennifer L Watson; Laurie Ryan; Nina Silverberg; Vicky Cahan; Marie A Bernard
Journal:  Health Aff (Millwood)       Date:  2014-04       Impact factor: 6.301

Review 3.  Dementia registries around the globe and their applications: A systematic review.

Authors:  Karolina Krysinska; Perminder S Sachdev; John Breitner; Miia Kivipelto; Walter Kukull; Henry Brodaty
Journal:  Alzheimers Dement       Date:  2017-05-30       Impact factor: 21.566

4.  Neuropathology Studies of Dementia in US Persons other than Non-Hispanic Whites.

Authors:  My-le Nguyen; Emily Z Huie; Rachel A Whitmer; Kristen M George; Brittany N Dugger
Journal:  Free Neuropathol       Date:  2022-03-10

5.  Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials?

Authors:  Mark S Cary; Jonathan D Rubright; Joshua D Grill; Jason Karlawish
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jan-Mar       Impact factor: 2.703

6.  Attitudes and Perceptions of Research in Aging and Dementia in an Urban Minority Population.

Authors:  Judith Neugroschl; Margaret Sewell; Angelica De La Fuente; Mari Umpierre; Xiaodong Luo; Mary Sano
Journal:  J Alzheimers Dis       Date:  2016-04-23       Impact factor: 4.472

7.  Hispanic Perspectives on Parkinson's Disease Care and Research Participation.

Authors:  Lisa Damron; Irene Litvan; Ece Bayram; Sarah Berk; Bernadette Siddiqi; Holly Shill
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

8.  Recruitment and retention strategies for minority or poor clinical research participants: lessons from the Healthy Aging in Neighborhoods of Diversity across the Life Span study.

Authors:  Ngozi Ejiogu; Jennifer H Norbeck; Marc A Mason; Bridget C Cromwell; Alan B Zonderman; Michele K Evans
Journal:  Gerontologist       Date:  2011-06

9.  What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer's Disease Biomarker Research? A Qualitative Vignette Analysis.

Authors:  Fred B Ketchum; Claire M Erickson; Nathaniel A Chin; Carey E Gleason; Nickolas H Lambrou; Susan Flowers Benton; Lindsay R Clark
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

10.  The Effectiveness of Community-based Outreach Events for the Promotion of African American Research Participation.

Authors:  Shoshana H Bardach; Justin M Barber; Frederick A Schmitt; Linda J Van Eldik; Morgan B Boggess; Markeda Yarbrough; Keisha C Jones; Gregory A Jicha
Journal:  Alzheimer Dis Assoc Disord       Date:  2020 Oct-Dec       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.